Outcomes Associated With Warfarin Use in Older Patients With Heart Failure and Atrial Fibrillation and a Cardiovascular Implantable Electronic Device: Findings From the ADHERE Registry Linked to Medicare Claims
Paul L. Hess(Duke University), Lesley H. Curtis(Duke University), Soko Setoguchi(Rutgers, The State University of New Jersey), Roger M. Mills(Janssen (Belgium)), Adrian F. Hernandez(Duke University), Gregg C. Fonarow(UCLA Medical Center), Sana M. Al‐Khatib(American Heart Association), Melissa A. Greiner(Duke University), Winslow Klaskala(Johnson & Johnson (United States))
Cited by 13
Related Papers
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
|American Heart Journal|2005|2.1k
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
|Circulation|2006|2.1k
The Global Health and Economic Burden of Hospitalizations for Heart Failure
|Journal of the American College of Cardiology|2014|2k